Red cell sodium in DOCA-salt hypertension a Brattleboro study Dotaz Zobrazit nápovědu
The alteration of red cell Na+ content (Na+i), its causes and the possible relationship to the development of DOCA-salt hypertension were studied in Brattleboro rats. A pronounced hypertension developed in heterozygous (non-DI) animals that synthesize vasopressin (VP) although no substantial Na+i elevation was observed in their erythrocytes. In contrast, Na+i rose progressively in red cells of homozygous VP-deficient (DI) rats in which only marginal increase of systolic blood pressure was found after six weeks of DOCA-salt regimen. DOCA-salt treatment of non-DI rats did not cause major alterations in ouabain-resistant (OR) net Na+ uptake or ouabain-sensitive (OS) net Na+ extrusion but moderately increased furosemide-sensitive (FS) Rb+ uptake. The same treatment of DI rats doubled Na+i by an increased OR net Na+ uptake (due to a major elevation in both Na(+)-K+ cotransport and Na+ leak). Consequently, OS net Na+ extrusion was augmented in red cells of these animals. This was accompanied by an about threefold elevated FS Rb+ uptake. It can be concluded that a) the alterations of OR and/or OS Na+ or K+ transport observed in erythrocytes of Brattleboro DI rats are not essential for the development of severe DOCA-salt hypertension, b) red cell ion transport abnormalities revealed in DOCA-salt treated DI rats might be rather ascribed to cell potassium depletion, and c) increased inward Na(+)-K+ cotransport and Na+ leak causes red cell Na+i elevation that stimulates Na(+)-K+ pump activity.
- MeSH
- aktivní transport účinky léků MeSH
- bumetanid farmakologie MeSH
- deoxykortikosteron MeSH
- erytrocyty účinky léků metabolismus MeSH
- furosemid farmakologie MeSH
- hematokrit MeSH
- hemoglobiny metabolismus MeSH
- hypertenze krev chemicky indukované patofyziologie MeSH
- kinetika MeSH
- krevní tlak MeSH
- krysa rodu Rattus MeSH
- nefrektomie MeSH
- ouabain farmakologie MeSH
- potkani Brattleboro MeSH
- rubidium krev MeSH
- sodík dietní * MeSH
- sodík krev MeSH
- techniky in vitro MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- bumetanid MeSH
- deoxykortikosteron MeSH
- furosemid MeSH
- hemoglobiny MeSH
- ouabain MeSH
- rubidium MeSH
- sodík dietní * MeSH
- sodík MeSH
Our previous study revealed major ion transport alterations that resulted in a pronounced elevation of red cell Na+ content in DOCA-salt treated homozygous vasopressin-deficient (DI) Brattleboro rats in which only a moderate increase of systolic blood pressure occurred. In contrast, no changes of red cell Na+ content were observed in heterozygous vasopressin-secreting (non-DI) Brattleboro rats with a severe DOCA-salt hypertension. Using a chronic supplementation of DI rats with an antidiuretic agonist dDAVP (1-desamino-8-D-arginine vasopressin) we did not demonstrate any significant changes of red cell ion transport in dDAVP-treated DI rats with a fully developed DOCA-salt hypertension. The absence of ion transport alterations seems to be mainly due to dDAVP-induced correction of altered K+ metabolism seen in DOCA-salt treated DI animals. It can be concluded that DOCA-salt hypertension can develop even without red cell ion transport alterations which are usually caused by cell K+ depletion.
- MeSH
- deoxykortikosteron MeSH
- desmopresin aplikace a dávkování MeSH
- draslík metabolismus MeSH
- erytrocyty metabolismus MeSH
- iontový transport MeSH
- krevní tlak MeSH
- krysa rodu Rattus MeSH
- osmolární koncentrace MeSH
- potkani Brattleboro MeSH
- renovaskulární hypertenze metabolismus MeSH
- sodík metabolismus MeSH
- tělesná hmotnost MeSH
- vasopresiny nedostatek MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- deoxykortikosteron MeSH
- desmopresin MeSH
- draslík MeSH
- sodík MeSH
- vasopresiny MeSH